ATE274066T1 - Neue polymerische komplexe für die transfektion von nukleinsaüren, mit resten für destabilisierung der zellmembranen - Google Patents
Neue polymerische komplexe für die transfektion von nukleinsaüren, mit resten für destabilisierung der zellmembranenInfo
- Publication number
- ATE274066T1 ATE274066T1 AT97945903T AT97945903T ATE274066T1 AT E274066 T1 ATE274066 T1 AT E274066T1 AT 97945903 T AT97945903 T AT 97945903T AT 97945903 T AT97945903 T AT 97945903T AT E274066 T1 ATE274066 T1 AT E274066T1
- Authority
- AT
- Austria
- Prior art keywords
- destabilization
- free
- groups
- residue
- cell membranes
- Prior art date
Links
- 210000000170 cell membrane Anatomy 0.000 title abstract 4
- 230000001687 destabilization Effects 0.000 title abstract 3
- 108020004707 nucleic acids Proteins 0.000 title abstract 2
- 150000007523 nucleic acids Chemical class 0.000 title abstract 2
- 102000039446 nucleic acids Human genes 0.000 title abstract 2
- 238000001890 transfection Methods 0.000 title 1
- 108010039918 Polylysine Proteins 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 239000000178 monomer Substances 0.000 abstract 2
- 229920000656 polylysine Polymers 0.000 abstract 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- 229940111121 antirheumatic drug quinolines Drugs 0.000 abstract 1
- 239000000460 chlorine Chemical group 0.000 abstract 1
- 229910052801 chlorine Chemical group 0.000 abstract 1
- 150000002016 disaccharides Chemical class 0.000 abstract 1
- 102000006240 membrane receptors Human genes 0.000 abstract 1
- 108020004084 membrane receptors Proteins 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 150000003248 quinolines Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9613990A FR2755976B1 (fr) | 1996-11-15 | 1996-11-15 | Nouveaux complexes d'acides nucleiques et de polymere substitue par des residus entrainant la destabilisation des membranes cellulaires |
| PCT/FR1997/002022 WO1998022610A1 (fr) | 1996-11-15 | 1997-11-10 | Nouveaux complexes polymeriques pour la transfection d'acides nucleiques, avec des residus destabilisant des membranes cellulaires |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE274066T1 true ATE274066T1 (de) | 2004-09-15 |
Family
ID=9497684
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97945903T ATE274066T1 (de) | 1996-11-15 | 1997-11-10 | Neue polymerische komplexe für die transfektion von nukleinsaüren, mit resten für destabilisierung der zellmembranen |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6372499B1 (https=) |
| EP (1) | EP0946744B1 (https=) |
| JP (1) | JP2001504344A (https=) |
| AT (1) | ATE274066T1 (https=) |
| AU (1) | AU742818B2 (https=) |
| CA (1) | CA2267833A1 (https=) |
| DE (1) | DE69730348T2 (https=) |
| ES (1) | ES2225992T3 (https=) |
| FR (1) | FR2755976B1 (https=) |
| IL (1) | IL128912A (https=) |
| WO (1) | WO1998022610A1 (https=) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6919076B1 (en) | 1998-01-20 | 2005-07-19 | Pericor Science, Inc. | Conjugates of agents and transglutaminase substrate linking molecules |
| WO2000032764A1 (en) * | 1998-12-02 | 2000-06-08 | I.D.M. Immuno-Designed Molecules | New oligomeric conjugates liable to transfer biological molecules into cells |
| AU7352200A (en) * | 1999-09-01 | 2001-03-26 | Regents Of The University Of California, The | Novel natriuretic peptide receptors, interacting compounds and methods of regulating proliferation and/or survival of neurons |
| US7070807B2 (en) | 1999-12-29 | 2006-07-04 | Mixson A James | Branched histidine copolymers and methods for using same |
| US7163695B2 (en) | 1999-12-29 | 2007-01-16 | Mixson A James | Histidine copolymer and methods for using same |
| EP1301213B1 (en) * | 2000-07-21 | 2017-01-18 | ReVance Therapeutics, Inc. | Multi-component biological transport systems |
| FR2812658B1 (fr) * | 2000-08-01 | 2005-04-15 | De Bruno Vandiere | Procede d'analyse d'acides nucleiques |
| US7465708B2 (en) | 2002-11-25 | 2008-12-16 | Mixson A James | Branched cationic copolymers and methods for antimicrobial use |
| CA2558676C (en) | 2004-03-03 | 2019-04-16 | Essentia Biosystems, Inc. | Compositions and methods for topical diagnostic and therapeutic transport |
| US9211248B2 (en) | 2004-03-03 | 2015-12-15 | Revance Therapeutics, Inc. | Compositions and methods for topical application and transdermal delivery of botulinum toxins |
| US8007814B2 (en) | 2004-06-16 | 2011-08-30 | University Of Massachusetts | Therapy for lysosomal enzyme deficiencies |
| US7740861B2 (en) | 2004-06-16 | 2010-06-22 | University Of Massachusetts | Drug delivery product and methods |
| US20060040879A1 (en) * | 2004-08-21 | 2006-02-23 | Kosak Kenneth M | Chloroquine coupled nucleic acids and methods for their synthesis |
| US20060094104A1 (en) * | 2004-10-29 | 2006-05-04 | Leopold Grillberger | Animal protein-free media for cultivation of cells |
| US20060211004A1 (en) | 2005-02-15 | 2006-09-21 | Ilsley Diane D | Methods and compositions for determining non-specific cytotoxicity of a transfection agent |
| SG160357A1 (en) | 2005-03-03 | 2010-04-29 | Revance Therapeutics Inc | Compositions and methods for topical application and transdermal delivery of botulinum toxins |
| CA2626394A1 (en) * | 2005-10-24 | 2007-05-03 | University Of Massachusetts | Yeast cell wall particle for delivering osteoprotegerin-encoding polynucleotide |
| JP2011517279A (ja) * | 2007-10-29 | 2011-06-02 | ユニバーシティ オブ マサチューセッツ | 核酸（ｓｉＲＮＡ）送達用の酵母細胞壁粒子（ＹＣＷＰ）多層状ナノ粒子 |
| FR2928373B1 (fr) * | 2008-03-05 | 2010-12-31 | Centre Nat Rech Scient | Polymere derive de la polyethylenimine lineaire pour le transfert de gene. |
| US8815818B2 (en) | 2008-07-18 | 2014-08-26 | Rxi Pharmaceuticals Corporation | Phagocytic cell delivery of RNAI |
| CA2746527A1 (en) | 2008-09-22 | 2010-03-25 | Rxi Pharmaceuticals Corporation | Rna interference in skin indications |
| US9493774B2 (en) | 2009-01-05 | 2016-11-15 | Rxi Pharmaceuticals Corporation | Inhibition of PCSK9 through RNAi |
| EP2678002A2 (en) | 2011-02-25 | 2014-01-01 | Medtronic, Inc. | Therapy for kidney disease and/or heart failure |
| EP2750697A4 (en) | 2011-09-02 | 2015-03-25 | Medtronic Inc | CHIMERIC NATRIURETIC PEPTIDE COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF |
| US9162191B2 (en) * | 2012-11-15 | 2015-10-20 | Board Of Trustees Of The University Of Alabama | Imidazole-containing polymer membranes and methods of use |
| CN102949729B (zh) * | 2012-11-20 | 2014-06-18 | 中国科学院宁波材料技术与工程研究所 | 主动靶向型小干扰核糖核酸输送载体及其制备方法 |
| WO2018195355A1 (en) | 2017-04-19 | 2018-10-25 | Rxi Pharmaceuticals Corporation | Topical delivery of nucleic acid compounds |
| AR122446A1 (es) * | 2020-04-29 | 2022-09-14 | Medimmune Llc | Composiciones y métodos para suministrar agentes farmacéuticamente activos |
| WO2022189361A1 (en) * | 2021-03-08 | 2022-09-15 | Universiteit Gent | Conjugates including multiple saccharidic chains on a linear protein and uses in mammals feed |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1316990A (en) * | 1970-09-17 | 1973-05-16 | Roche Products Ltd | Imidazolyl derivatives |
| US5166320A (en) * | 1987-04-22 | 1992-11-24 | University Of Connecticut | Carrier system and method for the introduction of genes into mammalian cells |
| JP2827287B2 (ja) * | 1988-07-05 | 1998-11-25 | 武田薬品工業株式会社 | 水溶性薬物含有徐放型マイクロカプセル |
| ES2090049T3 (es) * | 1989-03-16 | 1996-10-16 | Boehringer Ingelheim Int | Unidades geneticas para la inhibicion de la funcion de arn. |
| US5354844A (en) * | 1989-03-16 | 1994-10-11 | Boehringer Ingelheim International Gmbh | Protein-polycation conjugates |
| DE69125848T2 (de) * | 1990-12-19 | 1997-07-31 | Advanced Magnetics Inc | Targeting von therapeutischen mitteln durch verwendung von polysacchariden |
| DE4104186A1 (de) * | 1991-02-12 | 1992-08-13 | Genentech Inc | Neue, ueber endozytose in hoehere eukaryotische zellen aufnehmbare, nukleinsaeure enthaltende komplexe |
| EP0610441A4 (en) * | 1991-10-29 | 1996-01-10 | Clover Cons Ltd | CROSSLINKABLE POLYSACCHARIDES, POLYCATIONS AND LIPIDS CAN BE USED TO ENCODE AND DISPENSE MEDICINAL PRODUCTS. |
| DK0636028T3 (da) * | 1992-04-03 | 2004-07-12 | Univ California | Selvorganiserende polynucleotidleveringssystem omfattende et amfipatisk kationisk peptid |
| FR2719316B1 (fr) * | 1994-04-28 | 1996-05-31 | Idm | Nouveaux complexes d'acide nucléique et de polymère, leur procédé de préparation et leur utilisation pour la transfection de cellules. |
| US5733762A (en) * | 1994-04-28 | 1998-03-31 | I.D.M. Immuno-Designed Molecules | Complexes of nucleic acid and polymer, their process of preparation and their use for the transfection of cells |
| US6030941A (en) * | 1996-05-01 | 2000-02-29 | Avi Biopharma, Inc. | Polymer composition for delivering substances in living organisms |
-
1996
- 1996-11-15 FR FR9613990A patent/FR2755976B1/fr not_active Expired - Fee Related
-
1997
- 1997-11-10 EP EP97945903A patent/EP0946744B1/fr not_active Expired - Lifetime
- 1997-11-10 IL IL128912A patent/IL128912A/en not_active IP Right Cessation
- 1997-11-10 DE DE69730348T patent/DE69730348T2/de not_active Expired - Fee Related
- 1997-11-10 JP JP52325798A patent/JP2001504344A/ja not_active Ceased
- 1997-11-10 WO PCT/FR1997/002022 patent/WO1998022610A1/fr not_active Ceased
- 1997-11-10 AT AT97945903T patent/ATE274066T1/de not_active IP Right Cessation
- 1997-11-10 US US09/297,519 patent/US6372499B1/en not_active Expired - Fee Related
- 1997-11-10 CA CA002267833A patent/CA2267833A1/fr not_active Abandoned
- 1997-11-10 ES ES97945903T patent/ES2225992T3/es not_active Expired - Lifetime
- 1997-11-10 AU AU51239/98A patent/AU742818B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU742818B2 (en) | 2002-01-10 |
| ES2225992T3 (es) | 2005-03-16 |
| FR2755976A1 (fr) | 1998-05-22 |
| IL128912A (en) | 2006-06-11 |
| EP0946744A1 (fr) | 1999-10-06 |
| EP0946744B1 (fr) | 2004-08-18 |
| DE69730348D1 (de) | 2004-09-23 |
| DE69730348T2 (de) | 2005-09-01 |
| AU5123998A (en) | 1998-06-10 |
| US6372499B1 (en) | 2002-04-16 |
| WO1998022610A1 (fr) | 1998-05-28 |
| IL128912A0 (en) | 2000-02-17 |
| CA2267833A1 (fr) | 1998-05-28 |
| FR2755976B1 (fr) | 1999-01-15 |
| JP2001504344A (ja) | 2001-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE274066T1 (de) | Neue polymerische komplexe für die transfektion von nukleinsaüren, mit resten für destabilisierung der zellmembranen | |
| Hluchan et al. | Amino acids as corrosion inhibitors in hydrochloric acid solutions | |
| Coggins et al. | Use of dimethyl suberimidate and novel periodate-cleavable bis (imido esters) to study the quaternary structure of the pyruvate dehydrogenase multienzyme complex of Escherichia coli | |
| DE69528363D1 (de) | Neue nukleinsaure-polymer komplexe, verfahren zur deren herstellung und verwendung zur transfektion von zellen | |
| CA2179013A1 (en) | Polymers for Separation of Biomolecules by Capillary Electrophoresis | |
| Fojta et al. | Adsorption of peptide nucleic acid and DNA decamers at electrically charged surfaces | |
| Jelan et al. | Chemically reversible electroreduction of guanine in a polynucleotide chain | |
| DE69026716D1 (de) | Nukleinsäurefragmente von einem genom eines geeigneten mykobakteriums, ihre verwendung zur diagnose von mykobakterieninfektionen sowie diese fragmente enthaltende plasmide | |
| ATE389718T1 (de) | Isolierung von nukleinsäuren unter verwendung eines polykationischen polymers als fällungsmittel | |
| CA1187250A (en) | Polymeric polydonor complexons and the method thereof | |
| ATE260337T1 (de) | Neue oligomere konjugate zum transfer biologischer moleküle in zellen | |
| DE68925043D1 (de) | Synthetische Peptide und deren Mischungen für den Nachweis von HIV-Antikörpern | |
| DE69513579T2 (de) | Gel auf Basis eines Derivat von Glykosaminoglykan; Copolymers aus Acrylamid und diesem Derivat; Verfahren zum Nachweis von Enzymen | |
| KR910004766A (ko) | 도료용 수지조성물 | |
| KR940007056A (ko) | 단백질과 이 단백질을 코우드하는 dna 및 이 단백질의 제조방법 | |
| PT86616A (pt) | Verfahren zum nachgerben | |
| CN108931564A (zh) | 用于高灵敏度检测红霉素的3d镍金合金纳米簇印迹修饰电极 | |
| Habuchi et al. | Sea urchin egg receptor for sperm: the oligosaccharide chains stabilize sperm binding | |
| DE69030102T2 (de) | Chromogenes substrat | |
| DK0506823T3 (da) | Lavmolekylære copolymere amider | |
| Buckley et al. | Comparison of the adsorptive voltammetric behavior of avidin and streptavidin | |
| Novotný et al. | Interfacial behavior of thiosulfate on mercury electrode under voltammetric conditions | |
| Egashira et al. | Electrochemical preparation of a chelating polymer-modified electrode for selective incorporation of Ag (I) | |
| Abia | Polyaniline and its derivatives for environmental analysis | |
| SU469573A1 (ru) | Электролит дл электрохимического маркировани |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |